Biologics

ADAG

Adagene

Adagene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ADGI

Adagio Therapeutics

Adagio Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

ADCT

ADC Therapeutics

ADC Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

ADMA

ADMA Biologics

ADMA Biologics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

AFMD

Affimed

Affimed is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ALLK

Allakos

Allakos is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ALNY

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases. Investors watch platform execution, label expansion, and how new programs broaden the franchise.

AMAM

Ambrx Biopharma

Ambrx Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

APGE

Apogee Therapeutics

Apogee Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

APDN

Applied DNA SciencesDNA

Applied DNA SciencesDNA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ARGX

Argenx

Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ARNA

ARNA

ARNA is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.

ATYR

aTyr Pharma

aTyr Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

RNA

Avidity Biosciences

Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

AZYO

Aziyo Biologics

Aziyo Biologics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

BAVN

Bavarian Nordic

Bavarian Nordic is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

BNTX

BioNTech

BioNTech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

BWV

Blue Water Vaccines

Blue Water Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.

BBLG

Bone Biologics

Bone Biologics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

BCLI

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

CAPR

Capricor Therapeutics

Capricor Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

RNAC

Cartesian Therapeutics

Cartesian Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

CASI

CASI Pharmaceuticals Inc

CASI is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

DNAY

Codex DNA

Codex DNA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

CHRS

Coherus BioSciences, Inc.

Coherus BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

CMPX

Compass Therapeutics

Compass Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

CRVS

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

CRSP

CRISPR Therapeutics

CRISPR Therapeutics is a gene-editing company with exposure to cell therapy and genetic medicine. Investors watch the company for how its editing platform broadens beyond the first commercial and clinical milestones.

CTMX

CytomX Therapeutics, Inc.

CytomX Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

LLY

Eli Lilly

Eli Lilly is a large-cap pharmaceutical company with major exposure to cardiometabolic disease, neuroscience, and oncology. Investors track the stock for commercial scale, label expansion, and a pipeline that still carries meaningful growth optionality.

ETAO

Etao International Group

Etao International Group is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.

GMAB

Genmab

Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

GILD

Gilead Sciences

Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs. Investors track the balance between cash flow strength, launch execution, and pipeline replacement.

DNA

Ginkgo Bioworks Holdings, Inc.

GRNA

GreenLight Biosciences

GreenLight Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

GLSI

Greenwich LifeSciences

Greenwich LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

GSK

GSK plc

GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

HCWB

HCW Biologics

HCW Biologics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

IBIO

Ibio Inc

IBIO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

IMGN

ImmunoGen

ImmunoGen is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.

IMNM

Immunome

Immunome is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.

IMRN

Immuron

Immuron is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

IFRX

Inflarx NV

IFRX is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

TIL

Instil Bio

Instil Bio is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

IONS

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs. Investors watch platform depth, partner execution, and the pace of new launches.

IOVA

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics is a commercial-stage cell therapy company focused on tumor-infiltrating lymphocyte, or TIL, therapies for solid tumors. The company's story is centered on turning a complex personalized treatment approach into a scalable oncology franchise, with investors watching launch execution, adoption, and the broader expansion of the TIL platform.

JNJ

Johnson & Johnson

Johnson & Johnson is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

KYTX

Kyverna Therapeutics

Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.

LEGN

Legend Biotech Corporation

Legend Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

LCTX

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

MDNA

Medicenna Therapeutics Corp.

Medicenna Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

MRUS

Merus

Merus is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

MTD

Mettler-Toledo International, Inc.

Mettler-Toledo International is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.

MDXG

MiMedx

MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

MRNA

Moderna, Inc.

Moderna is an mRNA medicines company that built its platform around vaccine science and is now broadening into infectious disease, oncology, and other therapeutic areas. Investors watch how the company converts platform credibility into a wider commercial story.

NTRA

Natera

Natera is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

NAUT

Nautilus Biotechnology

Nautilus Biotechnology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

NVS

Novartis AG

Novartis AG is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

NVAX

Novavax

Novavax is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

OABI

OmniAb

OmniAb is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

ONCT

Oncternal Therapeutics

Oncternal Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.

PDSB

PDS Biotechnology Corporation

PDS Biotechnology is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

PFE

Pfizer, Inc.

Pfizer is a global pharmaceutical company with a diversified portfolio across vaccines, internal medicine, oncology, and other specialty areas. Investors track the stock for commercial scale, pipeline renewal, and the pace at which major programs translate into growth.

PMN

ProMIS Neurosciences

ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

HGEN

QHUMANIGEN INCD

QHUMANIGEN INCD is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

REGN

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a biologics-driven biopharmaceutical company built around antibody science, specialty-market execution, and a durable R&D engine. Investors watch both the commercial base and the next wave of pipeline readouts.

SNY

Sanofi

Sanofi is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

SRPT

Sarepta Therapeutics

Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.

SGEN

Seagen

Seagen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

SELB

Selecta

Selecta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

SLN

Silence Therapeutics

Silence Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

SYRE

Spyre Therapeutics, Inc.

Spyre Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

SURF

Surface Oncology

Surface Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.

STRO

Sutro Biopharma

Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

TCMD

Tactile Systems Technology, Inc.

Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

RNAZ

TransCode Therapeutics, Inc.

TransCode Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

TSBX

Turnstone Biologics

TSBX is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

VCNX

Vaccinex

Vaccinex is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.

VLA

Valneva

Valneva is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

VBIV

VBI Vaccines

VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.

VRNA

Verona Pharma

Verona Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

VINC

Vincerx Pharma

Vincerx Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

XNCR

Xencor

Xencor is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

YS

YS Biopharma

YS Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.